Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
NEW YORK (Reuters Health) – In children with urinary tract infection (UTI), trimethoprim (TMP) can be used as an alternative to trimethoprim/sulfamethoxazole (TMP/SMX) without compromising antibacterial activity, according…
Reza Jarrahy, MD, Assistant Professor, Division of Plastic and Reconstructive Surgery, UCLA, discusses challenges in craniofacial surgery, the holy grail of which is the search for a better…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses cardiovascular surgery research at UCLA, which aims to enhance patient outcomes by discovering…
Reza Jarrahy, MD, Assistant Professor, Division of Plastic and Reconstructive Surgery, UCLA, discusses Operation MEND, which is a collaboration UCLA has with the US Army to treat craniofacial…
NEW YORK (Reuters Health) – Including tirofiban (Aggrastat) in pre-hospital protocols can improve the outcomes of angioplasty for ST-segment elevation myocardial infarction (STEMI), according to randomized trial results.…
NEW YORK (Reuters Health) – Heparin bridging while withholding warfarin before implantation of a heart rhythm device substantially increases the risk of bleeding, new research shows. By contrast,…
NEW YORK (Reuters Health) – Computed tomography coronary angiography (CTCA) is most usefully applied in patients with intermediate risk for disease, because it will identify the ones who…
Hadassah Hospital, in Ein-Karem, Jerusalem, is currently constructing a new state-of-the-art building, making it one of the world’s leaders in technology and care in the hospital setting. Professor…
NEW YORK (Reuters Health) – Cerebral microbleeds increase the risk of intracerebral hemorrhage (ICH) in patients taking warfarin, a new study suggests. “These results have potentially worrying implications…
NEW YORK (Reuters Health) – Lipid-lowering therapy reduces cardiovascular events and all-cause mortality in patients with atrial fibrillation, according to a post hoc analysis of the AFFIRM study.…
